Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

CUSIP: 984241109

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
45,101,565
Total 13F shares
10,972,436
Share change
+2,510,918
Total reported value
$250,918,214
Price per share
$22.87
Number of holders
59
Value change
+$54,344,617
Number of buys
45
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 984241109?
CUSIP 984241109 identifies YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q2 2019

As of 30 Jun 2019, Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,972,436 shares. The largest 10 holders included Sofinnova Investments, Inc., FMR LLC, BlackRock Inc., Cormorant Asset Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Artal Group S.A., and STATE STREET CORP. This page lists 59 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.